SAGAMI Fumio | Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
スポンサーリンク
概要
- 同名の論文著者
- Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Aの論文著者
関連著者
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
KADOTA TOSHIHITO
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
Kadota Toshihito
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
KAI Shuichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Kimura Juki
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Saito Akemi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
NAGAYAMA Takashi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
SHIBATA Masami
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
SHIBATA Akiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
TANIGUCHI Katsuhiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
MATSUZAWA Toshiaki
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Kido Toshihito
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Shibata Akiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Shibata Masami
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Taniguchi Katsuhiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Nagayama Takashi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Matsuzawa Toshiaki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
NAGAYAMA Takashi
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
-
Kai Shuichi
ブリストルマイヤーズスクイブ
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Inoue Tohru
Biological Safety Res. Center National Inst. Of Health Sciences
-
KIDO Akihiko
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Kido Akihiko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Inoue Tohru
Biological Safety Research Center National Institute Of Health Sciences
-
OKAHASHI Noriko
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
IKEDA Takashi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KOMATSU Shinichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
MATSUI Hajime
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
YAMASHITA Yasuhiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
YAMAMOTO Keiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Matsui Hajime
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Okahashi Noriko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Okahashi Noriko
住友化学工業
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Satoh Kanako
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakae Dai
東京都健康安全研究センター
-
Nakae Dai
Tokyo Metropolitan Institute Of Public Health
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai-kato Kimie
Division Of Toxicology
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Ohkura Takako
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
KITAJIMA Satoshi
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Saito Mamoru
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Mutai Mamoru
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Onodera Horoshi
Pharmaceuticals and Medical Devices Agency
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
Urano Tsutomu
Pharmaceuticals and Medical Devices Agency
-
Komiyama Noriyuki
Pharmaceuticals and Medical Devices Agency
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
NAKAZAWA Takahiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
KAWAI Mutsufumi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
MAKI Eiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Kawano Shigeo
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Maki E
Japan Pharmaceutical Manufacturers Assoc. Tokyo Jpn
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
KOTOSAI Kounori
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KAWAHARA Jun-ichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
INOUE Akiharu
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
OHKURA Takako
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KOHIRA Terutomo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAGAKI Yasuhiro
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NEMOTO Shingo
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
MATSUMOTO Shinichi
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
NAITO Shinsaku
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Kawahara Jun-ichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sakemi Kazue
Division Of Pharmacology And Biological Safety Research Center National Institute Of Health Sciences
-
IWANAGA YUJI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
SAITO MAMORU
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
TORII SHINICHI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
TOYOSHIMA SHIGEKI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
NAKAI SHOJI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
HAMADA SHUICHI
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
HASHIMOTO MUNEHIRO
Non-Clinical Evaluation Subcommittee, Drug Evaluation, Japan Pharmaceutical Manufacturers Associatio
-
KIDO Toshihito
Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Kadota Toshihito
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kitajima S
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakai Shoji
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Iwanaga Yuji
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Inoue Akiharu
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Nemoto Shingo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Torii Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Hamada Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kohira Terutomo
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Yamashita Yasuhiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kitajima S
Division Of Cellular & Molecular Toxicology Biological Safety Research Center National Institute
-
Kitajima Satoshi
Division Of Cellular And Molecular Toxicology Biological Safety Research Center National Institute O
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Nagaki Yasuhiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kotosai Kounori
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Ikeda Takashi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Toyoshima Shigeki
Non-clinical Evaluation Subcommittee Drug Evaluation Japan Pharmaceutical Manufacturers Association
-
Hashimoto Munehiro
Nonclinical Regulatory Sciences Worldwide Safety Sciences Global Research & Development Nagoya L
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Matsumoto Shinichi
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Nakae Dai
Tokyo Metropolitan Inst. Of Public Health
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Saito Mamoru
Japan Pharmaceutical Manufactures Association (jpma) Basic Research A1 Group Glp Requirement Subteam
-
Naito Shinsaku
Non-clinical Evaluation Expert Committee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Association (jpma)
-
OHKURA Takako
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
著作論文
- The predictivity of preliminary embryo-fetal development (EFD) studies : results of a retrospective survey in Japanese pharmaceutical companies
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- S3-6 Problems and Meanings of Genome-based Drug Discovery in Japanese Pharmaceutical Companies(SYMPOSIUM 3: BENEFITS OF PHARMACOGENOMICS/PHARMACOGENETICS IN PHARMACEUTICAL DEVELOPMENT)(Proceedings of the 31st Annual Meeting)
- P8-49 Questionnaire Survey of GLP Operation for S7A Safety Pharmacology Study in Japanese and Foreign CROs(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-09 No-Observed Adverse Effect Level(NOAEL) : Judging Criteria and Purpose in Safety Assessment of Pharmaceuticals(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-08 Questionnaire Survey on No Observed Adverse Effect Level(2) : Regulatory Comments and Company(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- O-07 Questionnaire Survey on No Observed Adverse Effect Level(1) : Concept of NOAEL(STATISTICAL AND TEST METHODS/GENERAL TOXICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)